SEARCH

SEARCH BY CITATION

References

  • 1
    Espinal P, Roca I, Vila J. Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter. Future Microbiol 2011; 6: 495511.
  • 2
    Castellanos Martinez E, Telenti Asensio M, Rodriguez Blanco VM, Rodriguez Suarez ML, Morena Torrico A, Cortina Llosa A. Infective endocarditis of an interventricular patch caused by Acinetobacter haemolyticus. Infection 1995; 23: 243245.
  • 3
    Grotiuz G, Sirok A, Gadea P, Varela G, Schelotto F. Shiga toxin 2-producing Acinetobacter haemolyticus associated with a case of bloody diarrhea. J Clin Microbiol 2006; 44: 38383841.
  • 4
    Seifert H, Strate A, Schulze A, Pulverer G. Vascular catheter-related bloodstream infection due to Acinetobacter johnsonii (formerly Acinetobacter calcoaceticus var. lwoffi): report of 13 cases. Clin Infect Dis 1993; 17: 632636.
  • 5
    Doughari HJ, Ndakidemi PA, Human IS, Benade S. The ecology, biology and pathogenesis of Acinetobacter spp.: an overview. Microbes Environ 2011; 26: 101112.
  • 6
    Lambert T, Gerbaud G, Galimand M, Courvalin P. Characterization of Acinetobacter haemolyticus aac(6′)-ig gene encoding an aminoglycoside 6′-N-acetyltransferase which modifies amikacin. Antimicrob Agents Chemother 1993; 37: 20932100.
  • 7
    Quinteira S, Grosso F, Ramos H, Peixe L. Molecular epidemiology of imipenem resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital. Antimicrob Agents Chemother 2007; 51: 34653466.
  • 8
    Figueiredo S, Poirel L, Seifert H, Mugnier P, Benhamou D, Nordmann P. OXA-134, a naturally occurring carbapenem-hydrolyzing class D β-lactamase from Acinetobacter lwoffii. Antimicrob Agents Chemother 2010; 54: 53725375.
  • 9
    Héritier C, Poirel L, Fournier PE, Claverie JM, Raoult D, Nordmann P. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49: 41744179.
  • 10
    Poirel L, Figueiredo S, Cattoir V, Carattoli A, Nordmann P. Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob Agents Chemother 2008; 52: 12521256.
  • 11
    Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 2010; 16: 3540.
  • 12
    Nemec A, Krizova L, Maixnerova M et al. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus–Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 2011; 162: 393404.
  • 13
    Nemec A, Musílek M, Sedo O et al. Acinetobacter bereziniae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate Acinetobacter genomic species 10 and 11, respectively. Int J Syst Evol Microbiol 2010; 60: 896903.
  • 14
    Dortet L, Legrand P, Soussy CJ, Cattoir V. Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens. J Clin Microbiol 2006; 44: 44714478.
  • 15
    Bonnin RA, Nordmann P, Potron A, Lecuyer H, Zahar JR, Poirel L. Carbapenem hydrolyzing GES-type extended-spectrum β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2011; 55: 349354.
  • 16
    Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI M100-S21. Wayne, PA: CLSI, 2011.
  • 17
    Poirel L, Guibert M, Girlich D, Naas T, Nordmann P. Cloning, sequence analyses, expression, and distribution of ampC–ampR from Morganella morganii clinical isolates. Antimicrob Agents Chemother 1999; 43: 769776.
  • 18
    Fournier PE, Vallenet D, Barbe V et al. PLoS Genet 2006; 2: e7.
  • 19
    Couture F, Lachapelle J, Levesque RC. Phylogeny of LCR-1 and OXA-5 with class A and class D β-lactamases. Mol Microbiol 1992; 6: 16931705.
  • 20
    Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother 2010; 54: 2438.